Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 2

1.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

PMID:
24450891
[PubMed - indexed for MEDLINE]
Free Article
2.

Zolpidem-induced agitation and disorganization.

Hoyler CL, Tekell JL, Silva JA.

Gen Hosp Psychiatry. 1996 Nov;18(6):452-3. No abstract available.

PMID:
8937915
[PubMed - indexed for MEDLINE]

Supplemental Content

Loading ...
Write to the Help Desk